undamentalytics Newsletter
Sign in

Neuronetics, Inc. cash flow statement

In fiscal 2025, Neuronetics, Inc.'s operations generated −$20.4m of cash; it spent $801,000 on capital projects, leaving free cash flow of −$21.2m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−9−11−21−30−28−28−31−32−31−20−10
Depreciation and amortisation11111122232
Stock-based pay00234897676
Capital spending01111232111
Free cash flow−9−12−22−31−29−30−34−34−32−21−11
Free cash flow after stock pay−9−12−23−35−34−38−43−42−38−28−17
Shares issued—————81—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: INFU vs STIMRXST vs STIMBBNX vs STIMLAKE vs STIM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neuronetics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuronetics, Inc.